Pancreatic Cancer Research

Clinical trialObsNot yet recruiting

EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

Exploratory Study on EUS-guided Portal Vein CTCs and Their Subtypes Combined With Multi-omics Detection for Early Warning of Pancreatic Cancer Recurrence and Metastasis

NCT07448376↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
Obs
Status
Not yet recruiting
Study type
Observational
Start
1 March 2026
Expected end
30 December 2027
Enrollment
20 participants
Sites
1
Primary outcomes
Number of circulating tumor cells in the portal vein; Subpopulation classification of portal vein circulating tumor cells
Sponsor
Other
Results posted
No
Last update
4 March 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 9